Art Therapy for Cervicogenic Headache

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
National Intrepid Center of Excellence, Bethesda, MD
Cervicogenic Headache+19 More
Art Therapy - Behavioral
Eligibility
18 - 65
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing the effects of art therapy on posttraumatic stress in military service members. Art Therapy is a treatment that is used to treat Cervicogenic Headache. In this trial, there will be no patients who receive a placebo. This treatment is specifically for veterans. Art Therapy has been previously approved by the FDA for a different condition.

Eligible Conditions

  • Cervicogenic Headache
  • Post Traumatic Stress Disorder (PTSD)
  • Irritability
  • Military Family
  • Nightmares
  • Combat and Operational Stress Reaction
  • Military Operations
  • Stress Disorder, Combat
  • Posttraumatic Stress Disorder, Delayed Onset
  • Military Activity
  • Sleep Disturbance
  • Anger

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 9 Secondary · Reporting Duration: Week 10

Week 10
General Self Efficacy Scale (GSES)
Generalized Anxiety Disorder-7 (GAD-7)
Moral Injury Events Scale (MIES)
Neurobehavioral Symptoms Inventory (NSI)
PTSD Checklist for the Diagnostics and Statistics Manual Five (DSM-V) (PCL-5)
Perceived Stress Scale (PSS)
Revised Helping Alliance Questionnaire (HAQ-II)
Self-Regulation Questionnaire (SRQ)
The Measure is analysis of functional neuroimaging metrics
Toronto Alexithymia Scale (TAS-20)

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Art Therapy Arm
1 of 1
Experimental Treatment

25 Total Participants · 1 Treatment Group

Primary Treatment: Art Therapy · No Placebo Group · N/A

Art Therapy Arm
Behavioral
Experimental Group · 1 Intervention: Art Therapy · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Art Therapy
2016
Completed Phase 2
~550

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: week 10
Closest Location: National Intrepid Center of Excellence · Bethesda, MD
Photo of maryland 1Photo of maryland 2Photo of maryland 3
2020First Recorded Clinical Trial
0 TrialsResearching Cervicogenic Headache
1 CompletedClinical Trials

Who is running the clinical trial?

Walter Reed National Military Medical CenterLead Sponsor
124 Previous Clinical Trials
35,569 Total Patients Enrolled

Eligibility Criteria

Age 18 - 65 · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are eligible for the DEERS program.
You are separated from active duty or veteran within the past 5 years.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.